View Post Rapid HIV Testing in Transgender Communities by Community-Based Organizations in Three Cities. Public Health Reports, 123 (Suppl. 3): 101-114. In by AHFNovember 1, 2008
View Post Meningitis Due to Hematogenous Dissemination of Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) in a Patient with AIDS. Journal of the International Association of Physicians in AIDS Care, 7(6): 289-291. In by AHFNovember 1, 2008
View Post No Residual Activity of Raltegravir After Development of 148 Complex Mutations In Vivo. Journal of the International Association of Physicians in AIDS Care, 7(6): 281-282. In by AHFNovember 1, 2008
View Post Service Needs and Factors Related to Quality of Life at Time of Service Enrollment among Persons Living with HIV. Home Health Care Services Quarterly, 18(3): 43-63. In by AHFOctober 16, 2008
View Post Maraviroc for Previously Treated Patients with R5 HIV-1 Infection. The New England Journal of Medicine, 359: 1429-1441. In by AHFOctober 1, 2008
View Post Raltegravir: The First in a New Class of Integrase Inhibitors for the Treatment of HIV. Expert Review of Anti-Infective Therapy, 6(4): 419-426. In by AHFAugust 16, 2008
View Post Hepatitis C Patients’ Self-Reported Adherence to Treatment with Pegylated Interferon and Ribavirin. Alimentary Pharmacology & Therapeutics, 28: 289-293. In by AHFAugust 15, 2008
View Post Hepatitis C Patients’ Self-Reported Adherence to Treatment with Pegylated Interferon and Ribavirin. Alimentary Pharmacology and Therapeutics, 28: 289-293. In by AHFJuly 1, 2008
View Post False-Positivity of HIV-2 Immunoblots in a Cohort of Elite Suppressors Infected with HIV-1. Journal of Acquired Immune Deficiency Syndromes, 47(5): 644. In by AHFApril 1, 2008
View Post Darunavir: A New HIV-1 Protease Inhibitor for the Treatment of HIV Infection. Future HIV Therapy, 2(2): 125-136. In by AHFMarch 16, 2008
